Virtus Biotech ETF
14 hedge funds and large institutions have $10.7M invested in Virtus Biotech ETF in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
8% more funds holding
Funds holding: 13 → 14 (+1)
3% more capital invested
Capital invested by funds: $10.4M → $10.7M (+$308K)
0.96% more ownership
Funds ownership: 40.01% → 40.97% (+0.96%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SMG
Smart Money Group
Eastland,
Texas
|
+$293K |
| 2 |
NFG
Next Financial Group
Houston,
Texas
|
+$93K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$19.4K |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
+$9.73K |
| 5 |
PFS
Prospera Financial Services
Dallas,
Texas
|
+$5.12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$104K |
| 2 |
RWB
RMR Wealth Builders
Montclair,
New Jersey
|
-$41K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$28.6K |
| 4 |
LPL Financial
San Diego,
California
|
-$15.8K |
BBP Hedge Fund Activity: Q3 2020 in Review
14 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q3 2020, worth a combined $10.7M — up 3% from $10.4M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BBP positions and 2 closed out — a net gain of 1 holder — while 5 added to existing stakes and 2 trimmed.
The largest buyer was Smart Money Group, adding an estimated $293K. The largest seller was Private Advisor Group, exiting entirely with an estimated $104K sold.
- 14 institutional investors held Virtus Biotech ETF (BBP) as of Q3 2020, up from 13 in Q2 2020.
- Funds reported $10.7M of Virtus Biotech ETF stock for Q3 2020, up 3% quarter-over-quarter.
- 3 funds opened new Virtus Biotech ETF positions in Q3 2020 and 2 closed out, a net change of +1 holder.
- The largest Virtus Biotech ETF buyer in Q3 2020 was Smart Money Group, an estimated $293K added.
- The largest Virtus Biotech ETF seller in Q3 2020 was Private Advisor Group, an estimated $104K sold.
Based on aggregated 13F filings for Q3 2020.